IND Grade

As the genetic starting point for most cell and gene therapy products, plasmids are critical. Leveraging its GMP platform for nucleic acid therapeutics, Hillgene operates as a dedicated plasmid CDMO specializing in high-copy-number seed bank construction, high-density fermentation process development, and high-resolution purification methods. Our IND-level plasmid production system strictly follows GMP standards, yielding clinical-grade plasmids directly applicable for investigator-initiated trials (IIT) and IND submissions.